In vitro cytotoxic activity of equine lymphocytes on equine herpesvirus-1 infected allogenic fibroblasts.

This study explores how horse lymphocytes can fight against infection by equine herpesvirus-1 (EHV-1) in horse dermal fibroblasts, whether an incubation with interleukin-2 enhances this action, and if pregnancy affects this interaction.

Relevance of the Study

• This research aims to better understand how a horse’s immune response acts against the equine herpesvirus-1.
• Equine herpesvirus-1 is an infectious disease that causes respiratory disease, abortion in mares, neonatal death, and paralysis in horses.
• Such knowledge potentially opens doors to developing better treatment strategies and preventive measures against this destructive virus.

Key Experiments and Findings

• The researchers developed an approach to assess the capacity of horse lymphocytes (white blood cells) to destroy EHV-1 infected horse dermal fibroblasts in lab conditions.
• Attacks by lymphocytes were measured using a standard 4-hour 51Cr release test.
• The study discovered that incubating the lymphocytes with a protein called interleukin-2 for 72 hours enhances this attack, indicating interleukin’s role in strengthening the immune response.
• Interestingly, lymphocytes from non-pregnant horses were more efficient in destroying the virus than those from pregnant horses. However, the situation reversed after the interleukin-2 treatment – lymphocytes from pregnant mares responded better.

Investigating Further Connections

• The researchers also sought correlations between cytotoxic activity and the expression of five different cell surface markers. Surprisingly, no positive correlations were observed, meaning the identified cell types may not be directly responsible for the cytotoxic activity against EHV-1.
• Serum antibody levels (virus-neutralizing antibody titers) were also compared to the cytotoxic activity. However, the study did not elaborate on the findings for this measure.